期刊文献+

青岛地区不同宫颈病变组织中HPV16 E2基因突变分析 被引量:1

Analysis of the mutations of HPV16 E2 gene amony patients with different grades of cervical lesions in Qingdao
下载PDF
导出
摘要 目的:探讨山东省青岛地区不同宫颈病变组织中人乳头瘤病毒16型(HPV16)E2基因序列多态性,以及序列变异与不同宫颈病变的关系。方法:提取257例宫颈脱落细胞及宫颈癌组织DNA,PCR进行HPV分型,其中HPV16阳性标本扩增E2基因,测定PCR产物序列。通过DNAStar生物软件进行核苷酸和氨基酸序列分析。结果:共检测出11个碱基突变位点,其中10个导致氨基酸的改变,突变热点为nt3410(63.2%),nt3159(55.9%),nt3249(55.9%)。统计学分析显示,各个位点的突变与不同级别宫颈病变之间均无相关性(P>0.05)。宫颈癌标本中基因整合率为[65%(14/40)],远高于CINⅢ的整合率[14%(6/43)](P<0.001)。结论:青岛地区HPV16 E2基因存在多个位点的突变,且发现G2828A,T3274G,T3384C,T3524C为青岛地区特异性突变,这些位点的突变可能与高度上皮内瘤变和浸润性宫颈癌的发生和发展有关。 Objectives:To investigate the specific nucleotide variations in the human papillomavirus(HPV) 16 E2 DNA sequence in Qingdao of Shan dong Province.The association between the sequence variant and different cervical lesions was also assessed.Methods:The HPV16 E2 gene was amplified by PCR from fresh-frozen tissue as well as cervical-scraping cell lysates and sequenced it and then were compared with the standard strain.Results:A total of 11 nucleotide mutations were identified,while 10 of which resulted in amino acid changes.The hot spots of mutation were nt,3410(63.2%),3159(55.9%),3249(55.9%).The analysis revealed that there was no relation between the E2 mutation and degree of dysplasia(P0.05).The integration ratio was 65%(14 of 40) in the cervical cancer specimens,significantly more frequent than in CINⅢ lesions(6 of 43)(P0.001).Conclusion:In this study,there are several E2 sequence variations in HPV16 isolates in qingdao of china,G2828A,T3274G,T3384C,T3524C are found for the first time.These variants may be associated with the developing of cervical cancer.
出处 《现代妇产科进展》 CSCD 2012年第5期361-364,共4页 Progress in Obstetrics and Gynecology
基金 青岛市公共领域科技支撑计划项目[No:11-2-3-1-(8)-nsh]
关键词 宫颈病变 人乳头瘤病毒16型 E2基因 突变 Cervical diseases HPV16 E2 gene Variations
  • 相关文献

参考文献16

  • 1Bosch FX, de Sanjose S. Human papillomavirus and cervi- cal cancer-burden and assessment of causality [ J ]. J Natl Cancer Inst Monogr,2003,31:3-13.
  • 2Werness BA, Levine A J, Howley PM. Association of hu- man papillomavirus types 16 and 18 E6 protein with p53 [ J ]. Science, 1990,248 ( 4951 ) : 76-79.
  • 3彭俊,万艳平.人乳头瘤病毒E2蛋白对细胞增殖作用的研究进展[J].微生物学免疫学进展,2007,35(2):56-59. 被引量:2
  • 4Seedorf K, Krammer G, Durst M, et al. Human papilloma- virus type 16 DNA sequence [ J ]. Virol, 1985,145 ( 1 ) : 181-185.
  • 5Woodman CB, Collins S, Winter H, et al. Natural history of cervicalhuman papillomavirus infection in young women:longitudinalcohorts study [ J ]. Lancet, 2001,357 (9271) : 1831-1836.
  • 6Mattson MP, Cheng B, Burke RE, et al. Growth factor pro- tect neurons against excitotoxic/ischemic damage by sta- bilizing calcium homeostasis [ J ]. Stroke, 1993,24 ( 12 ) :136-138.
  • 7Demeret C, Gareia-Carranca A ,Thierry F, et al. Transcrip- tion independent triggering ofthe extrinsic pathway of apeptesis by human papillomavirusl8 E2 protein [ J ]. On- cogene, 2003,22 (2) : 168-175.
  • 8Parish JL, Kowalczyk A, Chen HT, et al. E2 proteins from high- and low-risk human, papillomavirus types difer in their ability to bind p53 and induce apoptotic cell death [ J]. J Virol,2006,80(6) :4580-4590.
  • 9Green KL, Southgate TD, Mulryan K, et al. Diffusible HPV22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy [ J]. Hum Gene Ther, 2006,17 ( 2 ) : 147-157.
  • 10Casas L, Galvan SC, Ordonez RM, et al. Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cer- vical carcinomas [ J ]. Int J Cancer, 1999,83 (4) : 449- 455.

二级参考文献18

  • 1Antson AA,Burns JE,Moroz OV,et al.Structure of the intact transactivation domain of the human papillomavirus E2 protein[J].Nature 2000,403(6771):805-809.
  • 2Corden SA,Sant-Cassia LJ,Easton AJ,et al.The integration of HPV-18 DNA in cervical carcinoma[J].Mol Pathol 1999,52(5):275-282.
  • 3Goodwin EC,DiMaio D.Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways[J].Proc Natl Acad Sci U S A 2000,97(23):12513-12518.
  • 4Schmidt MT,Olejnik AK,Gozdzicka-Jozefiak A.The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome[J].Acta Biochim Pol 2005,52(4):823-832.
  • 5Bechtold V,Beard P,Raj K.Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA[J].J Virol 2003,77(3):2021-2028.
  • 6Gammoh N,Grm HS,Massimi P,et al.Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator[J].J Virol 2006,80(4):1787-1797.
  • 7Nishimura A,Nakahara T,Ueno T,et al.Requirement of E7 oncoprotein for viability of HeLa cells[J].Microbes Infect 2006,8(4):984-993.
  • 8Grm HS,Massimi P,Gammoh N,et al.Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein[J].Oncogene 2005,24(33):5149-5164.
  • 9Demeret C,Garcia-Carranca A,Thierry F.Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein[J].Oncogene 2003,22(2):168-175.
  • 10Parish JL,Kowalczyk A,Chen HT,et al.E2 proteins from high-and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death[J].J Virol 2006,80(9):4580-4590.

共引文献1

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部